Market Place
Sourcing Support
All News #Library
Biotech
Greenwich Lifesciences Abstract Accepted At ASCO 2026
23 Apr 2026 //
GLOBENEWSWIRE
Greenwich LifeSciences Presents Open-Label Data at AACR Meeting
20 Apr 2026 //
GLOBENEWSWIRE
Greenwich Lifesciences Provides Update On Financing Strategy
14 Apr 2026 //
GLOBENEWSWIRE
Greenwich Lifesciences Adds City Of Hope To FLAMINGO-01 Study
19 Mar 2026 //
GLOBENEWSWIRE
Greenwich Lifesciences Provides Update On Upcoming AACR Meeting
18 Mar 2026 //
GLOBENEWSWIRE
Greenwich Lifesciences Reports Recurrence Rate Reduction
17 Mar 2026 //
GLOBENEWSWIRE
Greenwich Announces Use of Manufactured GP2 in FLAMINGO-01
16 Mar 2026 //
GLOBENEWSWIRE
Greenwich Provides Update on Increased Screen Rate in FLAMINGO-01
03 Mar 2026 //
GLOBENEWSWIRE
Greenwich LifeSciences: 2 Abstracts at 2026 AACR Meeting
24 Feb 2026 //
GLOBENEWSWIRE
Greenwich Lifesciences Updates FLAMINGO-01 Cash Burn Rate
27 Jan 2026 //
GLOBENEWSWIRE
FDA Approves Commercially Manufactured GP2 for FLAMINGO-01
22 Jan 2026 //
GLOBENEWSWIRE
Greenwich Lifesciences Updates FLAMINGO-01 Progress And Strategy
22 Dec 2025 //
GLOBENEWSWIRE
Greenwich Lifesciences Reports 80% Recurrence Rate Drop
15 Dec 2025 //
GLOBENEWSWIRE
Greenwich LifeSciences Completes FLAMINGO-01 Trial
08 Dec 2025 //
GLOBENEWSWIRE
Greenwich Life Sciences Screens 1,000+ in FLAMINGO-01 Trial
03 Dec 2025 //
GLOBENEWSWIRE
Greenwich Lifesciences Expands Flamingo-01 Trial To Belgium
02 Oct 2025 //
GLOBENEWSWIRE
Greenwich LifeSciences Expands Flamingo-01 Trial to Ireland
18 Sep 2025 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.